CPP-Ts: a new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells

Bárbara Bruna Ribeiro de Oliveira-Mendes1, Carolina Campolina Rebello Horta2, Anderson Oliveira do Carmo1

  • 1Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Minas Gerais, Brazil.

Scientific Reports
|October 5, 2018
PubMed

Insights

Researchers discovered a new toxin, CPP-Ts, in Tityus serrulatus scorpion venom that affects heart cells by increasing calcium release. This toxin also shows potential for targeted cancer drug delivery to the cell nucleus.

Area of Science:

  • Toxicology
  • Cardiology
  • Biotechnology
  • Molecular Biology

Background:

  • Scorpion envenoming is a global health issue, with cardiac complications causing significant mortality.
  • Cardiac dysfunction is a primary cause of death in scorpion sting victims.
  • The specific mechanisms of scorpion venom-induced cardiotoxicity are not fully understood.

Purpose of the Study:

  • To identify and characterize novel toxins in Tityus serrulatus venom.
  • To investigate the effects of a newly identified toxin on cardiomyocyte function.
  • To explore the potential of this toxin as a nuclear-targeting drug delivery system for cancer therapy.

Main Methods:

  • Isolation and characterization of a novel toxin, CPP-Ts, from Tityus serrulatus venom.
  • Assessment of CPP-Ts's effect on intracellular calcium release in cardiomyocytes via nuclear InsP3R activation.
  • Evaluation of a synthetic CPP-Ts sub-peptide for nuclear targeting in cancer cell lines.

Main Results:

  • Identification of CPP-Ts, the first Ca2+ channel toxin from Tityus serrulatus venom, characterized as a cell-penetrating peptide.
  • CPP-Ts activates nuclear InsP3R in cardiomyocytes, leading to increased intracellular Ca2+ release and enhanced contraction frequency.
  • A synthetic CPP-Ts sub-peptide (14-39) demonstrated nuclear-targeting capabilities in specific cancer cell lines without pharmacological activity.

Conclusions:

  • Tityus serrulatus venom contains a novel subfamily of Ca2+ active toxins, exemplified by CPP-Ts.
  • CPP-Ts represents a new class of toxins affecting cardiomyocyte contractility through nuclear calcium signaling.
  • The nuclear-targeting property of CPP-Ts offers promising biotechnological applications for targeted cancer drug delivery systems.

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.3K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.7K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.5K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.8K
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
863
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.7K